Liu, Feng-Ting <br/><br/>
CD126 and Targeted Therapy with Tocilizumab in Chronic Lymphocytic Leukemia.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  05 2016 
 - 2462-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-15-1139  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>B-Lymphocytes--drug effects<br/>Cell Cycle--drug effects<br/>Cyclin E--metabolism<br/>Cyclin-Dependent Kinase 2--metabolism<br/>Drug Resistance, Neoplasm--drug effects<br/>Female<br/>Humans<br/>Interleukin-6--metabolism<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Male<br/>Middle Aged<br/>Molecular Targeted Therapy--methods<br/>Myeloid Cell Leukemia Sequence 1 Protein--metabolism<br/>Proliferating Cell Nuclear Antigen--metabolism<br/>Receptors, Interleukin-6--metabolism<br/>STAT3 Transcription Factor--metabolism<br/>Tumor Cells, Cultured<br/>bcl-X Protein--metabolism